Faculty of International Social Sciences

伊地知 新太

イヂチ シンタ  (Shinta Ijichi)

基本情報

所属
学習院大学 理学部 生命科学科 博士研究員
学位
博士 (理学)(2026年3月 学習院大学)

J-GLOBAL ID
202401007940628598
researchmap会員ID
R000068749

論文

 8
  • Shotaro Hoshino, Emiko Nagai, Hisayuki Komaki, Shinta Ijichi, Shumpei Asamizu, Hiroyasu Onaka
    The Journal of Antibiotics 2026年7月24日  
  • Shinta Ijichi, Shotaro Hoshino, Emiko Nagai, Shumpei Asamizu, Hiroyasu Onaka
    ACS Synthetic Biology 2026年7月3日  査読有り筆頭著者
  • Shotaro Hoshino, Shinta Ijichi, Hiroyasu Onaka
    Chemical and Pharmaceutical Bulletin 73(8) 698-706 2025年8月15日  査読有り筆頭著者
  • Shotaro Hoshino, Shinta Ijichi, Shumpei Asamizu, Hiroyasu Onaka
    Journal of the American Chemical Society 145(32) 17863-17871 2023年8月16日  査読有り
    The unique bioactivities of arsenic-containing secondary metabolites have been revealed recently, but studies on arsenic secondary metabolism in microorganisms have been extremely limited. Here, we focused on the organoarsenic metabolite with an unknown chemical structure, named bisenarsan, produced by well-studied model actinomycetes and elucidated its structure by combining feeding of the putative biosynthetic precursor (2-hydroxyethyl)arsonic acid to Streptomyces lividans 1326 and detailed NMR analyses. Bisenarsan is the first characterized actinomycete-derived arsenic secondary metabolite and may function as a prototoxin form of an antibacterial agent or be a detoxification product of inorganic arsenic species. We also verified the previously proposed genes responsible for bisenarsan biosynthesis, especially the (2-hydroxyethyl)arsonic acid moiety. Notably, we suggest that a C-As bond in bisenarsan is formed by the intramolecular rearrangement of a pentavalent arsenic species (arsenoenolpyruvate) by the cofactor-independent phosphoglycerate mutase homologue BsnN, that is entirely distinct from the conventional biological C-As bond formation through As-alkylation of trivalent arsenic species by S-adenosylmethionine-dependent enzymes. Our findings will speed up the development of arsenic natural product biosynthesis.
  • Shinta Ijichi, Shotaro Hoshino, Shumpei Asamizu, Hiroyasu Onaka
    Bioorganic & medicinal chemistry letters 89 129323-129323 2023年6月1日  査読有り筆頭著者
    Ribosomally synthesized and posttranslationally modified peptides (RiPPs) with polar-functionalized fatty acyl groups are newly found lipopeptide-class natural products. We recently employed a combined approach of genome mining and stable isotope labeling and discovered solabiomycins as one of the polar-functionalized fatty-acylated RiPPs (PFARs) from Streptomyces lydicus NBRC13058. The solabiomycins contained a characteristic sulfoxide group in the labionin moiety referred to as the 'solabionin' structure for the RiPP moiety. A previous gene knockout experiment indicated that solS, which encodes a putative flavin adenine dinucleotide (FAD)-nicotinamide adenine dinucleotide (phosphate) (NAD(P))-binding protein, is involved in the sulfoxidation of an alkyl sulfide in the solabionin. In this study, we isolated deoxysolabiomycins A and B from ΔsolS mutant and fully determined the chemical structures using a series of NMR experiments. We also tested the bioactivity of deoxysolabiomycins against Gram-positive bacteria, including Mycolicibacterium smegmatis, and notably found that the sulfoxide is critical for the antibacterial activity. To characterize the catalytic activity of SolS, the recombinant protein was incubated with a putative substrate, deoxysolabiomycins, and the cofactors FAD and NADPH. In vitro reactions demonstrated that SolS catalyzes the sulfoxidation, converting deoxysolabiomycins to solabiomycins.

MISC

 1

講演・口頭発表等

 20

所属学協会

 4

共同研究・競争的資金等の研究課題

 1